ANEST IWATA Corp. AI Stock Analysis
Want to see JP:6381 full AI Analyst Report?
ANEST IWATA Corp. (6381) AI Stock Analysis
ANEST IWATA Corp.
(TSE/TYO:6381)
The company's rock-solid balance sheet and consistent profitability form a strong foundation, but the stock is under significant technical pressure, trading below key moving averages with weak momentum. An attractive low P/E and high dividend yield partially offset the bearish technicals, resulting in a moderately positive overall score. The primary risk is the sustained negative price trend, while the primary strength is the company's exceptional financial health.
ANEST IWATA Corp. (6381) vs. iShares MSCI Japan ETF (EWJ)
- Market Cap
- JPY 63.77B
- Dividend Yield
- 5.34%
- Average Volume (3M)
- 95.02K
- Price to Earnings (P/E)
- 11.1
- Beta (1Y)
- 0.86
- Revenue Growth
- 13.76%
- EPS Growth
- 38.30%
- Country
- Japan
- Employees
- 1,897
- Sector
- Industrials
- Sector Strength
- 63
- Industry
- Industrial - Machinery
ANEST IWATA Corp. Business Overview & Revenue Model
Company Description
Established in Yokohama, Japan, in 1926, ANEST IWATA Corporation is a global enterprise specializing in air energy and coating technologies. Its air energy division provides a broad range of products, including air compressors and nitrogen gas genera...
ANEST IWATA Corp. Financial Statement Overview
Summary
Strong overall financial health. The balance sheet is exceptional (95) with minimal debt and growing equity. The income statement shows steady revenue growth and improving net margins, though operating margin softened slightly. Cash flow is solid, converting 61% of net income to free cash flow, despite a year-over-year decline.
Income Statement
75PositiveBalance Sheet
95Very PositiveCash Flow
70Positive| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 61.06B | 55.91B | 54.41B | 53.42B | 48.52B | 42.34B |
| Gross Profit | 28.31B | 26.14B | 26.08B | 24.48B | 21.34B | 18.23B |
| EBITDA | 9.21B | 8.05B | 8.39B | 8.43B | 7.91B | 6.54B |
| Net Income | 5.84B | 5.36B | 4.28B | 4.93B | 4.38B | 3.54B |
Balance Sheet | ||||||
| Total Assets | 75.53B | 74.64B | 69.96B | 66.14B | 60.14B | 55.82B |
| Cash, Cash Equivalents and Short-Term Investments | 18.05B | 20.75B | 21.34B | 16.93B | 14.51B | 14.32B |
| Total Debt | 3.23B | 2.74B | 2.87B | 3.07B | 2.67B | 2.42B |
| Total Liabilities | 17.96B | 17.09B | 16.40B | 16.07B | 14.88B | 15.61B |
| Stockholders Equity | 51.01B | 50.75B | 46.85B | 44.16B | 40.03B | 35.62B |
Cash Flow | ||||||
| Free Cash Flow | 0 | 4.94B | 7.08B | 4.95B | 2.48B | 3.02B |
| Operating Cash Flow | 0 | 8.14B | 9.75B | 6.77B | 4.33B | 3.89B |
| Investing Cash Flow | 0 | -4.33B | -3.25B | -1.26B | -3.32B | -1.08B |
| Financing Cash Flow | 0 | -3.86B | -3.93B | -3.58B | -2.36B | -2.10B |
ANEST IWATA Corp. Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:6381, the sentiment is Negative. The current price of 1668.00 is below the 20-day moving average (MA) of 1705.50, below the 50-day MA of 1804.84, and below the 200-day MA of 1696.27, indicating a bearish trend. The MACD of -38.61 indicates Negative momentum. The RSI at 36.22 is Neutral, neither overbought nor oversold. The STOCH value of 65.47 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:6381.
ANEST IWATA Corp. Peers Comparison
Overall Rating
JP:633376Outperform
JP:636376Outperform
JP:651771Outperform
JP:623770.25Outperform
JP:638169.25Neutral
JP:637665Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 76Outperform | JPY 48.51B | 12.79 | ― | 4.30% | 2.49% | -8.96% | |
| 76Outperform | JPY 63.85B | 5.76 | ― | 2.66% | -1.87% | 215.36% | |
| 71Outperform | JPY 66.85B | 10.28 | ― | 4.16% | 9.85% | 33.61% | |
| 70Outperform | JPY 83.79B | 13.92 | ― | 2.27% | 13.01% | 28.70% | |
| 69Neutral | JPY 67.10B | 11.09 | ― | 5.34% | 13.76% | 38.30% | |
| 65Neutral | JPY 163.62B | 9.45 | 10.86% | 1.94% | 12.76% | 63.89% | |
| Sector * | 63Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |
* Industrials Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| JP:6381 | ANEST IWATA Corp. | 1668.00 | 234.62 | 16.37% | |
| JP:6376 | Nikkiso Co., Ltd. | 2680.00 | 1197.68 | 80.80% | |
| JP:6237 | Iwaki Co. Ltd. | 3825.00 | 1494.76 | 64.15% | |
| JP:6333 | Teikoku Electric Manufacturing Co., Ltd. | 3345.00 | 531.32 | 18.88% | |
| JP:6363 | Torishima Pump Mfg.Co., Ltd. | 2480.00 | 677.70 | 37.60% | |
| JP:6517 | Denyo Co., Ltd. | 3365.00 | 371.12 | 12.40% |
ANEST IWATA Corp. Corporate Events
ANEST IWATA Approves 43-Yen Interim Dividend
ANEST IWATA said its board approved a 43-yen-per-share interim dividend for the fiscal year ending March 31, 2027, for shareholders of record on Sept. 30, 2026. The payment includes a 41-yen ordinary dividend and a 2-yen commemorative dividend, total...
ANEST IWATA Reports FY2026 Second-Quarter Sales and Profit Growth
ANEST IWATA Corporation, a machinery company, operates businesses spanning air compressors, vacuum equipment, coating equipment and coating systems, with market activity in Japan, the United States, India and Europe. For FY2026’s second quarter, net...
ANEST IWATA Reports FY2026 Interim Sales and Profit Growth
ANEST IWATA Corporation reported net sales of ¥31,478 million for the FY2026 interim period ended September 30, 2026, up 19.6% year over year, while operating profit rose 44.3% to ¥3,623 million. Ordinary profit increased 28.7% to ¥4,241 million and...
ANEST IWATA Sharpens Board Governance With Effectiveness Review and Committee Overhaul
ANEST IWATA reported the results of its FY2025 evaluation of board effectiveness, based on an anonymous third-party survey of nine directors covering 15 board meetings from April 2025 to March 2026. The review assessed board structure and management,...
ANEST IWATA Corrects Share Buyback Figures and Period in Updated Disclosure
ANEST IWATA Corporation has issued a correction to its previously disclosed notice on the status and completion of its share buyback program. The company identified an error in the earlier figures and has now updated the total shares acquired and the...
ANEST IWATA Nears Ceiling on ¥1.5 Billion Share Buyback Program
ANEST IWATA Corporation has completed a share repurchase program authorized by its board in May 2026, acquiring a total of 843,600 common shares on the Tokyo Stock Exchange for approximately 1.5 billion yen. The latest tranche, executed between Septe...
ANEST IWATA Nears Buyback Limit After Aggressive August Share Repurchases
ANEST IWATA Corporation reported the latest progress of its ongoing share repurchase program, buying 273,800 common shares for approximately 519 million yen via market purchases on the Tokyo Stock Exchange between August 1 and August 31, 2026. This t...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Nov 17, 2026
